---
figid: PMC5891174__CAS-109-893-g003
figlink: /pmc/articles/PMC5891174/figure/cas13530-fig-0003/
number: Figure 3
caption: Loss of p53‐binding protein 1 (53BP1)‐induced resistance mechanism to poly(ADP‐ribose)
  polymerase (PARP) inhibitor in breast cancer susceptibility gene 1 (BRCA1)‐ and
  breast cancer susceptibility gene 2 (BRCA2)‐deficient cells through double‐strand
  break (DSB) repair and ensuing pathways during the S/G2 cell cycle phase were compared.
  Pathway differences in PARP inhibitor sensitivity with additional loss of 53BP1
  were analyzed in (A) BRCA1‐deficient and (B) BRCA2‐deficient cells. CDK, cyclin‐dependent
  kinase; CtIP, C‐terminal‐binding protein interacting protein; DNA‐PKcs, DNA‐dependent
  protein kinase catalytic subunit; HR, homologous recombination; Lig4, DNA ligase
  IV; NHEJ, non‐homologous end joining; RIF1, Rap1‐interacting factor 1
pmcid: PMC5891174
papertitle: Crosstalk of DNA double‐strand break repair pathways in poly(ADP‐ribose)
  polymerase inhibitor treatment of breast cancer susceptibility gene 1/2‐mutated
  cancer.
reftext: Shigeaki Sunada, et al. Cancer Sci. 2018 Apr;109(4):893-899.
pmc_ranked_result_index: '33140'
pathway_score: 0.9514443
filename: CAS-109-893-g003.jpg
figtitle: Crosstalk of DNA double‐strand break repair pathways in poly(ADP‐ribose)
  polymerase inhibitor treatment of breast cancer susceptibility gene 1/2‐mutated
  cancer.
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5891174__CAS-109-893-g003.html
  '@type': Dataset
  description: Loss of p53‐binding protein 1 (53BP1)‐induced resistance mechanism
    to poly(ADP‐ribose) polymerase (PARP) inhibitor in breast cancer susceptibility
    gene 1 (BRCA1)‐ and breast cancer susceptibility gene 2 (BRCA2)‐deficient cells
    through double‐strand break (DSB) repair and ensuing pathways during the S/G2
    cell cycle phase were compared. Pathway differences in PARP inhibitor sensitivity
    with additional loss of 53BP1 were analyzed in (A) BRCA1‐deficient and (B) BRCA2‐deficient
    cells. CDK, cyclin‐dependent kinase; CtIP, C‐terminal‐binding protein interacting
    protein; DNA‐PKcs, DNA‐dependent protein kinase catalytic subunit; HR, homologous
    recombination; Lig4, DNA ligase IV; NHEJ, non‐homologous end joining; RIF1, Rap1‐interacting
    factor 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK1
  - CDKL2
  - CDK11B
  - CDKL5
  - CDK10
  - CDKL1
  - CDK20
  - CDKL4
  - CDK11A
  - CDK13
  - LIG4
  - RAD51
  - RIF1
  - CDK2
  - CDK9
  - CDK19
  - CDK3
  - CDK8
  - CDKL3
  - CDK16
  - CDK14
  - CDK15
  - BRCA2
  - CDK12
  - CDK5
  - CDK17
  - BRCA1
  - CDK4
  - RBBP8
  - CDK6
  - CDK7
  - CDK18
  - ENG
  - TP53BP1
genes:
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: LIG4
  symbol: LIG4
  source: hgnc_symbol
  hgnc_symbol: LIG4
  entrez: '3981'
- word: Rad51
  symbol: RAD51
  source: hgnc_symbol
  hgnc_symbol: RAD51
  entrez: '5888'
- word: RIF1
  symbol: RIF1
  source: hgnc_symbol
  hgnc_symbol: RIF1
  entrez: '55183'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: BRCA2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: BRCA1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CtIP
  symbol: CtIP
  source: hgnc_alias_symbol
  hgnc_symbol: RBBP8
  entrez: '5932'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: ČDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: end
  symbol: END
  source: hgnc_alias_symbol
  hgnc_symbol: ENG
  entrez: '2022'
- word: 53BP1
  symbol: 53BP1
  source: hgnc_alias_symbol
  hgnc_symbol: TP53BP1
  entrez: '7158'
chemicals: []
diseases: []
---
